Alissa Neufeld - Lifevantage General Secretary
| LFVN Stock | USD 14.20 1.04 7.90% |
Executive
Alissa Neufeld is General Secretary of Lifevantage
| Age | 44 |
| Address | 3300 North Triumph Boulevard, Lehi, UT, United States, 84043 |
| Phone | 801 432 9000 |
| Web | https://www.lifevantage.com |
Alissa Neufeld Latest Insider Activity
Tracking and analyzing the buying and selling activities of Alissa Neufeld against Lifevantage stock is an integral part of due diligence when investing in Lifevantage. Alissa Neufeld insider activity provides valuable insight into whether Lifevantage is net buyers or sellers over its current business cycle. Note, Lifevantage insiders must abide by specific rules, including filing SEC forms every time they buy or sell Lifevantage'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Alissa Neufeld over six months ago Disposition of 4201 shares by Alissa Neufeld of Lifevantage at 6.185 subject to Rule 16b-3 |
Lifevantage Management Efficiency
The company has return on total asset (ROA) of 0.0601 % which means that it generated a profit of $0.0601 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1451 %, meaning that it created $0.1451 on every $100 dollars invested by stockholders. Lifevantage's management efficiency ratios could be used to measure how well Lifevantage manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to drop to -0.32. In addition to that, Return On Capital Employed is likely to drop to -0.52. At this time, Lifevantage's Non Current Assets Total are very stable compared to the past year. As of the 22nd of November 2024, Non Currrent Assets Other is likely to grow to about 950.6 K, while Total Assets are likely to drop about 30.9 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Howard CPA | Central Garden Pet | 61 | |
| Howard Machek | Central Garden Pet | 61 | |
| William Pennington | Central Garden Pet | N/A | |
| Aron Kolosik | Central Garden Pet | N/A | |
| Brad Smith | Central Garden Pet | N/A | |
| Glen Axelrod | Central Garden Pet | N/A | |
| Marilyn Leahy | Central Garden Pet | N/A | |
| Mary Kehoe | J J Snack | 62 | |
| Ken Elsbury | Central Garden Pet | N/A | |
| Howard CPA | Central Garden Pet | 61 | |
| Paul Lister | Associated British Foods | 59 | |
| Chris Cole | Bridgford Foods | N/A | |
| Bjoern Leyser | J J Snack | N/A | |
| Lynwood Mallard | J J Snack | 55 | |
| Brad Smith | Central Garden Pet | N/A | |
| Friederike Edelmann | Central Garden Pet | N/A | |
| Friederike Edelmann | Central Garden Pet | N/A | |
| Marilyn Leahy | Central Garden Pet | N/A | |
| John Exner | Seneca Foods Corp | 62 | |
| William Pennington | Central Garden Pet | N/A | |
| Chris Walter | Central Garden Pet | N/A | |
Management Performance
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0601 |
Lifevantage Leadership Team
Elected by the shareholders, the Lifevantage's board of directors comprises two types of representatives: Lifevantage inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lifevantage. The board's role is to monitor Lifevantage's management team and ensure that shareholders' interests are well served. Lifevantage's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lifevantage's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carl Aure, Chief Officer | ||
| Steven Fife, CEO President | ||
| Julie Boyster, Chief Officer | ||
| Kristen Cunningham, Chief Officer | ||
| Michelle ObornVirchow, Vice President - Human Resources | ||
| Calli Mott, Senior Experience | ||
| Eric Marchant, Vice Compliance | ||
| Chris Taylor, Director Communications | ||
| Steven CPA, CEO President | ||
| Robert Harris, Chief Officer | ||
| Dave Fleming, VP Sales | ||
| Alissa Neufeld, General Secretary | ||
| Carl CPA, Chief Officer | ||
| Eiichi Shiokawa, Managing Japan | ||
| Alissa JD, General Secretary | ||
| Matthew Cooley, Chief Officer |
Lifevantage Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lifevantage a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0601 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 160.72 M | ||||
| Shares Outstanding | 12.53 M | ||||
| Shares Owned By Insiders | 16.89 % | ||||
| Shares Owned By Institutions | 37.13 % | ||||
| Number Of Shares Shorted | 258.49 K | ||||
| Price To Earning | 4.65 X |
Pair Trading with Lifevantage
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifevantage position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifevantage will appreciate offsetting losses from the drop in the long position's value.Moving against Lifevantage Stock
| 0.86 | CL | Colgate Palmolive Fiscal Year End 24th of January 2025 | PairCorr |
| 0.78 | EPC | Edgewell Personal Care | PairCorr |
| 0.75 | KMB | Kimberly Clark Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.7 | UL | Unilever PLC ADR | PairCorr |
| 0.7 | NUS | Nu Skin Enterprises | PairCorr |
The ability to find closely correlated positions to Lifevantage could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifevantage when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifevantage - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifevantage to buy it.
The correlation of Lifevantage is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifevantage moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifevantage moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifevantage can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifevantage. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Lifevantage Stock, please use our How to Invest in Lifevantage guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifevantage. If investors know Lifevantage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifevantage listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.8 | Dividend Share 0.15 | Earnings Share 0.32 | Revenue Per Share 15.853 | Quarterly Revenue Growth (0.08) |
The market value of Lifevantage is measured differently than its book value, which is the value of Lifevantage that is recorded on the company's balance sheet. Investors also form their own opinion of Lifevantage's value that differs from its market value or its book value, called intrinsic value, which is Lifevantage's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifevantage's market value can be influenced by many factors that don't directly affect Lifevantage's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifevantage's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifevantage is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifevantage's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.